Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Pharmacology|June 17, 2014
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphateL J Williams, D Mukherjee, M Fisher, et al.
British Journal of Cancer|December 1, 1996
Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modificationG M Tozer, V E Prise, K M Bell, et al.
The Journal of Pathology|May 10, 2007
The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancersS P Gunningham, M J Currie, H R Morrin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Screening for depression among patients with multiple sclerosis: two questions may be enoughD C Mohr, S L Hart, L Julian, et al.
The Journal of Gene Medicine|October 17, 2001
Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseasesE J Estruch, S L Hart, C Kinnon, et al.
European Journal of Pharmacology|June 2, 1994
Antinociceptive activity of peptides related to interleukin-1 beta-(193-195), Lys-Pro-ThrA O Oluyomi, S Poole, T W Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2006
Treatment of depression for patients with multiple sclerosis in neurology clinicsD C Mohr, S L Hart, I Fonareva, et al.
Anticancer Research|April 13, 2001
Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivoS M Galbraith, D J Chaplin, F Lee, et al.
NIDA Research Monograph|January 1, 1986
Stress-induced-antinociception and morphine sensitivity in mice following chronic treatment with anabolic/androgenic steroidsD A Cowan, S Friend, A Gibson, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 10, 2003
Pulmonary gene therapy. Realistic hope for the future, or false dawn in the promised land?R G Jenkins, R J McAnulty, S L Hart, et al.
Pageof 14